Back to Trades
Smith Hunter C
Chief Financial OfficerCIK 0001636385
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 31
- Companies
- 1
- Active
- 2025–2026
Smith Hunter C, Chief Financial Officer, has filed 8 SEC reports (2025–2026), all concentrated in RHYTHM PHARMACEUTICALS, INC. (RYTM), totaling $22.7M in disclosed volume. Weighing $0 bought versus $14.9M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Sep 1 | RYTM RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Chief Financial Officer | Sell | $6.6M |
| Mar 2 | RYTM RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Chief Financial Officer | Exercise | $82.9K |
| Feb 19 | RYTM RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Chief Financial Officer | Sell | $805.8K |
| Feb 12 | RYTM RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Chief Financial Officer | Sell | $708.6K |
| Feb 6 | RYTM RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Chief Financial Officer | Sell | $702.7K |
| Aug 14 | RYTM RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Chief Financial Officer | Sell | $2.7M |
| Jul 11 | RYTM RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Chief Financial Officer | Sell | $3.4M |
| Jul 8 | RYTM RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Chief Financial Officer | Exercise | $96.1K |
8 filings